PITUITARY ADENYLYL CYCLASE-ACTIVATING PEPTIDE (PACAP) DEFICIENT MICE  
UCLA Technology Available For Licensing

BACKGROUND:  Pituitary adenylate cyclase-activating polypeptide (PACAP) is a 38-amino acid peptide that was first isolated from ovine hypothalamic extracts. It has been previously observed that light information reaches the suprachiasmatic nucleus through a population of retinal ganglion cells that contain PACAP, however the involvement of PACAP and its receptor is not well studied. In order to study the role of PACAP in vivo, a new mouse model was developed in which the gene encoding for PACAP was disrupted by homologous recombination.

INNOVATION:  PACAP deficient mice exhibit significant impairment in the magnitude of the response to brief light exposures. Researches observed about a 50% reduction in the magnitude of both light-induced phase delays and advances of the circadian system in the PACAP deficient mice. Overall, loss of PACAP produced selective deficits in the light response of the circadian system.

POTENTIAL APPLICATIONS 

Related Papers (Selected)

Reference: UCLA Case No. 2001-466

For additional technical details and current licensing
availability, please contact the following UCLA office:

UCLA Office of Intellectual Property
11000 Kinross Avenue, Suite #200
Los Angeles, CA 90095
Tel: 310-794-0558 Fax: 310-794-0638
email: ncd@research.ucla.edu
NCD URL:   http://www.research.ucla.edu/tech/ucla01-466.htm

Lead Inventor: James Waschek

UCLA Technologies Available for Licensing
http://www.research.ucla.edu/oipa/industry

Copyright © 2008 The Regents of the University of California.

keywords: research tools mouse models drug development uclancd ucla latest inventions technology top ten 10 technologies intellectual property patents technology transfer invention business card